Seeking Alpha Author Bret Jenson breaks down why he thinks the biotech stock Invitae is positioned for a quick rise and predicts where the industry will be be in the next 5 years.
Seeking Alpha Author Bret Jenson breaks down why he thinks the biotech stock Invitae is positioned for a quick rise and predicts where the industry will be be in the next 5 years.